Jeffrey W. Albers
2020
In 2020, Jeffrey W. Albers earned a total compensation of $6.3M as President and Chief Executive Officer at Blueprint Medicines, a 32% decrease compared to previous year.
Compensation breakdown
| Non-Equity Incentive Plan | $545,025 |
|---|---|
| Option Awards | $2,710,242 |
| Salary | $645,000 |
| Stock Awards | $2,435,850 |
| Other | $8,550 |
| Total | $6,344,667 |
Albers received $2.7M in option awards, accounting for 43% of the total pay in 2020.
Albers also received $545K in non-equity incentive plan, $645K in salary, $2.4M in stock awards and $8.6K in other compensation.
Rankings
In 2020, Jeffrey W. Albers' compensation ranked 1,615th out of 13,090 executives tracked by ExecPay. In other words, Albers earned more than 87.7% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 1,615 out of 13,090 | 88th |
Division Manufacturing | 608 out of 5,621 | 89th |
Major group Chemicals And Allied Products | 217 out of 2,254 | 90th |
Industry group Drugs | 181 out of 1,954 | 91st |
Industry Pharmaceutical Preparations | 126 out of 1,459 | 91st |
Pay ratio
| Jeffrey W. Albers' Pay | $6,344,667 |
|---|---|
| Median Employee's Pay | $332,124 |
| Pay Ratio | 19to 1 |
In 2020, the annual total compensation of Jeffrey W. Albers was $6,344,667.
The annual total compensation of the median employee at Blueprint Medicines was $332,124.
The ratio of Jeffrey W. Albers' pay to the pay of median employee was therefore 19 to one.
Source: SEC filing on April 21, 2021.
Albers' colleagues
We found four more compensation records of executives who worked with Jeffrey W. Albers at Blueprint Medicines in 2020.